These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22901111)
1. Research progress in potential urinary markers for the early detection, diagnosis and follow-up of human bladder cancer. Wang HF; Wang JS Asian Pac J Cancer Prev; 2012; 13(5):1723-6. PubMed ID: 22901111 [TBL] [Abstract][Full Text] [Related]
4. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Ng K; Stenzl A; Sharma A; Vasdev N Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875 [TBL] [Abstract][Full Text] [Related]
6. Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer. Mutlu N; Turkeri L; Emerk K Clin Chem Lab Med; 2003 Aug; 41(8):1069-74. PubMed ID: 12964816 [TBL] [Abstract][Full Text] [Related]
7. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project. Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893 [TBL] [Abstract][Full Text] [Related]
8. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles. Oeyen E; Hoekx L; De Wachter S; Baldewijns M; Ameye F; Mertens I Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769831 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review. Bosschieter J; Lutz C; Segerink LI; Vis AN; Zwarthoff EC; A van Moorselaar RJ; van Rhijn BW; Heymans MW; Jansma EP; Steenbergen RD; Nieuwenhuijzen JA Epigenomics; 2018 May; 10(5):673-687. PubMed ID: 29692199 [TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer. Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578 [TBL] [Abstract][Full Text] [Related]
15. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors. Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer. D Elia C; Pycha A; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Vjaters E; Pycha A; Trenti E J Clin Pathol; 2019 Feb; 72(2):140-144. PubMed ID: 30355587 [TBL] [Abstract][Full Text] [Related]
17. Current Use and Promise of Urinary Markers for Urothelial Cancer. Tabayoyong W; Kamat AM Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534 [TBL] [Abstract][Full Text] [Related]
18. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder. Lekili M; Sener E; Demir MA; Temeltaş G; Müezzinoğlu T; Büyüksu C Urol Res; 2004 May; 32(2):124-8. PubMed ID: 14685796 [TBL] [Abstract][Full Text] [Related]
20. [Bladder cancer screening with urine-based tumour markers - occupational medical experience]. Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]